Chemical, Pharmacologic, and Physical Agents Causing Hypomelanoses

The Pigmentary System: Physiology and Pathophysiology: Second Edition

Volumn , Issue , 2007, Pages 669-685

  Briganti, Stefania ^a   Ottaviani, Monica ^a   Picardo, Mauro ^a   Lacour, Jean Phillipe ^b  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Benzothiazine; Catechols; Eumelanogenesis; Hypomelanoses; Melanocortin 1 receptor

Indexed keywords

EID: 84889625775     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987100.ch35     Document Type: Chapter

References (191)

1. Amer M., and M. Metwalli. Topical liquiritin improves melasma. Int. J. Dermatol. 39:299-301, 2000.
2. Ando, H., A. Ryu, A. Hashimoto, M. Oka, and M. Ichashi. Linoleic and α-linoleic acid lightens ultraviolet-induced hyperpigmentation of the skin. Arch. Dermatol. Res. 290:375-381, 1998.
3. Barker, D., K. Dixon, E. E. Medrano, D. Smalara, S. Im, D. Mitchell, G. Babcock, and Z. Abdel-Malek. Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B irradiation. Cancer Res. 55:4041-4046, 1995.
4. Battaini, G., E. Monzani, L. Casella, L. Santagostini, and R. Pagliarin. Inhibition of catecholase activity of biomimetic dinuclear copper complexes by kojic acid. J. Biol. Inorg. Chem. 5:262-268, 2000.
5. Benedetto, J. P., J. P. Ortonne, C. Voulot, C. Khatchadourian, G. Prota, and J. Thivolet. Role of thiol compounds in mammalian melanin pigmentation II. Glutathione and related enzymatic activities. J. Invest. Dermatol. 79:422-424, 1982.
6. Bernard, P., and J. Y. Berthon. Resveratrol: an original mechanism on tyrosinase inhibition. Int. J. Cosmetic Science 22:219-226, 2000.
7. Bertolotto, C., P. Abbe, T. J. Hemesath, K. Bille, D. E. Fisher, J. P. Ortonne, and R. Ballotti. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell. Biol. 142:827-835, 1998.
8. Billingham, R., and W. Silvers. Studies on the migratory behavior of melanocytes in guinea pig skin. J. Exp. Med. 131:101, 1990.
9. Bleehen, S. S. Disorders of skin colour. In: Textbook of Dermatology, R. H. Champion, J. L. Burton, D. A. Burns, S. M. Breathnach, Rook/Wilkinson/Ebling (eds). Oxford: Blackwell Science, 1998, pp. 1753-1815.
10. Bleehen, S. S., M. A. Pathak, Y. Hori, and T. B. Fitzpatrick. Depigmentation of skin with 4-isopropylcatechol, mercaptoamines and other compounds. J. Invest Dermatol. 50:103-117, 1968.
11. Bocchietto, E., L. Pecis, F. D'Abrosca, N. Losio, and M. Picardo. In vitro testing of innovative depigmenting and low toxicity topic compositions. Pigment Cell Res. 14:405, 2001.
12. Boissy, R. E. Melanosome transfer to and translocation in the keratinocyte. Exp. Dermatol. 13:5-12, 2003.
13. Boissy, R., and P. Manga. On the etiology of contact/occupational vitiligo. Pigment Cell Res. 17:208-214, 2004.
14. Bolognia, J. L., S. A. Sodi, and J. M. Pawelek. Two separate pathways in the regulation of pigmentation. J. Invest. Dermatol. 96:632, 1991.
15. Bolognia, J. L., S. A. Sodi, M. P. Obser, and J. M. Pawelek. Enhancement of the depigmenting effect of hydroquinone by cystamine and buthionine sulfoxime. Br. J. Dermatol. 133:349-357, 1995.
16. Breathnach, A. S. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. Cutis 57:36-45, 1996.
17. Briganti S., E. Camera, and M. Picardo. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res. 16:101-110, 2003.
18. Bulengo-Ransby, S. M., E. M. Griffiths, C. K. Kimbrough-Green, L. J. Finkel, T. A. Hamilton, C. N. Ellis, and J. J. Voorhees. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N. Engl. J. Med. 328:1438-1443, 1993.
19. Calnan, C. D. Occupational leukoderma from alkyl phenols. Proc. R. Soc. Med. 66:258-260, 1973.
20. Cameli, N., W. Marmo, A. Gaeta, G. Calderini, and M. Picardo. Evaluation of clinical efficacy of a mixture of depigmenting agents. Pigment Cell Res. 14:406, 2001.
21. Castagnet, J., and J. P. Ortonne. Pigmentary changes in aged and photoaged skin. Arch. Dermatol. 133:1296-1299, 1997.
22. Chakraborty, A. K., Y. Funasaka, M. Komoto, and M. Ichihashi. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res. 11:206-212, 1998.
23. Choi, S. Y., S. Kim, J. S. Hwang, B. G. Lee, H. Kim, and S. Y. Kim. Benzylamide derivative compound attenuates the ultraviolet B-induced hyperpigmentation in the brownish guinea pig skin. Biochem. Pharmacol. 67:707-715, 2004.
24. Choi, S., Y. I. Park, S. K. Lee, J. E. Kim, and M. H. Chung. Aloesin inhibits hyperpigmentation induced by UV radiation. Exp. Dermatol. 27:513-515, 2002.
25. Cummings, M. P., and J. J. Nordlund. Chemical leukoderma: fact or fancy. Am J. Contact Derm. 6:122-127, 1995.
26. Curto, E. V., C. Kwong, H. Hermersdorfer, H. Glatt, C. Santis, V. Virador, V. J. Hearing Jr, and T. P. Dooley. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gen-tisic acid with other putative inhibitors. Biochem. Pharmacol. 57:663-72, 1999.
27. D'Ischia, M., A. Napolitano, and G. Prota. Peroxidase as an alternative to tyrosinase in the oxidative polymerization of 5,6-dihydrox-yindoles to melanin(s). Biochim. Biophys. Acta 1073: 423-430, 1991.
28. Denton, C. R., A. B. Lerner, and T. B. Fitzpatrick. Inhibition of melanin formation by chemical agents. J. Invest Dermatol. 18:119-134, 1952.
29. Dooley, T. P., R. C. Gadwood, K. Kilgore, and L. M. Thomasco. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol. 7: 188-200, 1994.
30. Erol, O., and K. Atabay. The treatment of burn scar hypopigmenta-tion and surface irregularity by dermoabrasion and thin skin grafting. Plast. Reconst. Surg. 85:754-758, 1990.
31. Fang, D., Y. Tsuji, and V. Setaluri. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucl. Acids Res. 30: 3096-3106, 2002.
32. Fenoll, L. G., J. N. Rodriguez-Lopez, R. Varon, P. A. Garcia-Ruiz, F. Garcia-Canovas, and J. Tudela. Action mechanism of tyrosinase on meta-and para-hydroxylated monophenols. Biol. Chem. 38:313-320, 2000.
33. Fisher, A. A. The safety of bleaching creams containing hydroquinone. Cutis 61:303-304, 1998.
34. Fleicher, A. B., E. H. Schwartzel, S. I. Colby, and D. J. Altman. The combination of 2 % 4-hydroxy anisole (Mequinol) and 0,01 % tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies. J. Am. Acad. Dermatol. 42: 459-467, 2000.
35. Franchi, J., M. C. Coutader, C. Marteau, M. Mersel, and A. Kupferberger. Depigmenting effects of calcium D-pantetheine-S-sulfonate on human melanocytes. Pigment Cell Res. 13: 165-171, 2000.
36. Frenk, E. Treatment of melasma with depigmenting agents. In: Melasma: New approaches to treatment, Martin Dunitz Ltd., London, 1995, pp. 9-15.
37. Funayama, M., H. Arakawa, R. Yamamoto, T. Nishimo, T. Shin, and S. Murao. Effect of alpha-and beta-arbutin on activity of tyrosi-nases from mushroom and mouse melanoma. Biosci. Biotech. Biochem. 59: 143-144, 1995.
38. Furumura, M., F. Solano, N. Matsunaga, C. Sakai, R. A. Spritz, and V. J. Hearing. Metal ligand-binding specificities of the tyrosinase-related proteins. Biochem. Biophys. Res. Commun. 242: 579-585, 1998.
39. Gaskell, M., K. I. McLuckie and P. B. Farmer. Genotoxicity of the benzeme metabolities para-benzoquinone and hydroquinone. Chem. Biol. Interact. 153-154:267-270, 2005.
40. Gellin, G. A., H. I. Maibach, and M. H. Misiaszek. Detection of environmental depigmenting substances. Contact Dermatitis 5:201-213, 1979.
41. Gilchrest, B. A., F. B. Blog, and G. Szabo. Effects of aging and chronic sun exposure on melanocytes in human skin. J. Invest. Dermatol. 73:141-143, 1979.
42. Gili, A., P. D. Thomas, M. Ota, and K. Jimbow. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity. Melanoma Res. 10.9-15, 2000.
43. Gordon, P. R., and B. A. Gilchrest. Human melanogenesis is stimulated by diacylglycerol. J. Invest. Dermatol. 93.700-702, 1989.
44. Graham, G. F. Cryosurgery. Clin. Plast. Surg. 20:131-147, 1993.
45. Guevara, I. L., and A. G. Pandya. Melasma treated with hydro-quinone, tretinoin and a fluorinated steroid. Int. J. Dermatol. 40.212-215, 2001.
46. Hachiya, A., T. Kobayashi, Y. Takema, and G. Imokawa. Biochemical characterization of endothelin-converting enzyme-1α in cultured skin-derived cells and its postulated role in the stimulation of melanogenesis in human epidermis. J. Biol. Chem. 277.5395-5403, 2002.
47. Hakozaki, T., L. Minwalla, J. Zhuang, M. Choa, A. Matsubara, K. Miayamoto, A. Greatens, G. G. Hillebrand, D. L. Bissett, and R. E. Boissy. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br. J. Dermatol. 147:20-31, 2002.
48. Halcin, C., S. K. Hann, and Y. C. Kauh. Vitiligo following the resolution of psoriatic plaques during PUVA therapy. Int. J. Dermatol. 36:534-536, 1997.
49. Hashiya, A., A. Kobayashi, A. Ohuci, Y. Takema, and G. Imokawa. The paracrine role of stem cell factor/c-kit signalling in the activation of human melanocytes in ultraviolet-B-induced pigmentation. J. Invest. Dermatol. 116.578-586, 2001.
50. Hazen, H. Results of repeated epilation with roentgen rays in tinea tonsurans. Arch. Dermatol. 56:539-540, 1947.
51. Hearing, V. J., and R. A. King. In: Pigmentation and Pigmentary Disorders, part 2, L. Norman (ed.). Boca Raton: CRC Press, 1993, pp. 5-31.
52. Hunt, G., S. Kyne, S. Ito, K. Wakamatsu, C. Todd, and A. J. Thody. Eumelanin and pheomelanin content of human epidermis and cultured melanocytes. Pigment Cell Res. 8:202-208, 1997.
53. Hwang, J. S., H. Choi, H. S. Rho, H. J. Shin, D. H. Kim, J. Lee, B. G. Lee, and I. Chang. Pigment-lightening effect of N-N'-dilinoleylcystamine on human melanoma cells. Br. J. Dermatol. 150:39-46, 2004.
54. Ichihashi, M., Y. Funasaka, A. Ohashi, A. Chakraborty, N. U. Ahmed, M. Ueda, and T. Osaka. The inhibitory effect of DL-alpha-tocopheryl ferulate in lecithin on melanogenesis. Anticancer Res. 19:3769-3774, 1999.
55. Im, S., J. Kim, W. Y. On, and W. H. Kang. Increased expression of α-melanocyte-stimulating-hormone in the lesional skin of melasma. Br. J. Dermatol. 146:165-167, 2002.
56. Imokawa, G., T. Kobayashi, M. Miyagishi, K. Higashi, and Y. Yada. The role of endothelin-1 in epidermal hyperpigmentation and signalling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res.10: 218-228, 1997.
57. Imokawa, G., Y. Yada, N. Morisaki, and M. Kimura. Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes. Biochem. J. 330.1235-1239, 1998.
58. Imokawa, G., Y. Yada, N. Morisaki, M. Kimura. Granulocyte/macrophage-colony-stimulating factor is an intrinsic keratinocyte-derived growth factor for human melanocytes in UVA-induced melanosis. Biochem. J. 313.625-631, 1996.
59. Ito, S., and G. Prota. A facile one-step synthesis of cysteinyldopas using mushroom tyrosinase. Experientia 33: 118-119, 1977.
60. Jahaveri, S. M., S. Handa, I. Kaur, and B. Kumar. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int. J. Dermatol. 40:354-357, 2001.
61. Jang, M., L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. H. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, and J. M. Pezzuto. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
62. Jimbow, K., W. C. Quevedo, T. B. Fitzpatrick, and G. Szabo. Some aspects of melanin biology. J. Invest. Dermatol. 67:72-89, 1976.
63. Jimbow, M., H. Marusyk, and K. Jimbow. The in vivo melanocyto-toxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair. Br. J. Dermatol. 133.526-536, 1995.
64. Jimenez-Cervantes, C., M. Martinez-Esparza, C. Perez, N. Daum, F. Solano, and J. C. Garcia-Borron. Inhibition of melanogenesis in response to oxidative stres: transient downregulation of melanocyte differentiation markers and possible involvement of microphtalmia transcription factor. J. Cell Science 14: 2335-2344, 2001.
65. Jin, Y. H., S. J. Lee, M. H. Chung, J. H. Park, J. I. Park, T. H. Cho, and S. K. Lee. Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch. Pharm. Res. 22:232-236, 1999.
66. Jones, K., J. Hughes, M. Hong, Q. Jia, and S. Orndorff. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res. 15:335-340, 2002.
67. Kadekaro, A. L., R. J. Kavanagh, K. Wakamatsu, S. Ito, M. A. Pipitone, and Z. A. Abdel-Malek. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round? Pigment Cell Res. 16.434, 2003.
68. Kageyama, A., M. Oka, T. Okada, M. Nakamura, T. Ueyama, N. Saito, V. J. Hearing, M. Ichihashi, and C. Nishigori. Down regulation of melanogenesis by phospholipase D2 through ubiquitin proteasome-mediated degradation of tyrosinase. J. Biol. Chem. 279.27774-27780, 2004.
69. Kahn, A., and M. Cohen. Treatment of depigmentation following burn injuries. Burns 77.552-559, 1996.
70. Kahn, V. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase. Pigment Cell Res. 8.234-240, 1995.
71. Kameyama, K., C. Sakai, S. Kondoh, K. Yonemoto, S. Nishiyama, M. Tagawa, T. Murata, T. Ohnuma, J. Quigley, A. Dorsky, D. Bucks, and K. Blanock. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J. Am. Acad. Dermatol. 34.29-33, 1996.
72. Kang, W. H., K. H. Yoon, E. S. Lee, J. Kim, K. B. Lee, H. Yim, S. Sohn, and S. Im. Melasma: histopathological characteristics in 56 Korean patients. Br. J. Dermatol. 146:228-237, 2002.
73. Kang, W. H., S. C. Chun, and S. Lee. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic, hydro-quinone and hydrocortisone): clinical and histological studies. J. Dermatol. 25.587-589, 1998.
74. Karg, E., G. Odh, A. Wittbjer, E. Rosengren, and H. Rorsman. Hydrogen peroxide as inducer of elevated tyrosinase level in melanoma cells. J. Invest. Dermatol. 100.209s-213s, 1993.
75. Kasraee, B. Peroxidase-mediated mechanisms are involved in the melanocytotoxic and melanogenesis-inhibiting effects of chemical agents. Dermatology 205:329-339, 2002 a.
76. Kasraee, B. Depigmentation of brown guinea pig skin by topical application of methimazole. J. Invest. Dermatol. 118.205-207, 2002 b.
77. Kauh, Y. C., and T. F. Zachian. Melasma. Adv. Exp. Med. Biol. 455.191-499, 1999.
78. Kim, D. S., S. H. Park, S. B. Kwon, K. Li, S. W. Youn, K. C. Park. (-) Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production. Arch. Pharm. Res. 27:334-339, 2004.
79. Kim, D. S., S. Y. Kim, J. H. Chung, K. H. Kim, H. C. Eun, and K. C. Park. Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal 14: 779-785, 2002.
80. Kim, D. S., S. Y. Kim, S. J. Moon, J. H. Chung, K. H. Kim, K. H. Cho, and K. C. Park. Ceramide inhibits cell proliferation through AktPKB inactivation and decreases melanin synthesis in Mel-Ab cells. Pigment Cell Res. 14:110-115, 2001.
81. Kim, Y. M., J. Yun, C. K. Lee, H. Lee, K. R. Min, and Y. Kim. Oxyresveratrol and hydroxystilbene compounds: inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 277: 16340-16344, 2002.
82. Kin, D. H., J. S. Hwang, H. S. Baek, K. J. Kim, B. G. Lee, I. Chang, H. H. Kang, and O. K. Lee. Development of 5-[(3-aminopropyl)phosphinooxyl]-2-(hydroxymethyl)-4H-pyran-4-one as a novel whitening agent. Chem. Pharm. Bull. 51:113-116, 2003.
83. Kitawaki, A., Y. Tanaka, and K. Takada. New findings on the mechanism of post-inflammatory pigmentation. Pigment Cell Res. 16:603, 2003.
84. Klaus, S. N. Pigment transfer in mammalian epidermis. Arch. Dermatol. 100:756-762, 1969.
85. Kobayashi, T., G. Imokawa, D. C. Bennett, and V. J. Hearing. Tyrosinase stabilization by Tyrp1 (the brown locus protein). J. Biol. Chem. 273:31801-31805, 1998.
86. Kurosu, J., T. Sato, K. Yoshida, T. Tsugane, S. Shimura, K. Kirimura, K. Kino, and S. Usami. J. Biosci. Bioeng. 93:328-330, 2002.
87. Lacz, N. L., J. Vafaie, N. I. Kihiczak, and R. A. Schwartz. Postin-flammatory hyperpigmentation: a common but troubling condition. Int. J. Dermatol. 43:362, 2004.
88. Lemic-Stoicevic, L., A. H. Nias, and A. S. Breathnach. Effect of azelaic acid on melanoma cell in culture. Exp. Dermatol. 4:79-81, 1995.
89. Lim, J. T. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol. Surg. 25:282-284, 1999.
90. Lin, C. B., F. Babiarz, E. Liebel, R. Price, M. Kizoulis, G. J. Gendimenicop, D. E. Fisher, and M. Seigìberg. Modulation of Microphthalmia-associated transcription factor gene expression alters skin pigmentation. J. Invest. Dermatol. 119:1330-1340, 2002.
91. Lo, Y. Y. C., J. M. S. Wong, and T. F. Cruz. Reactive oxygen species mediate cytokine activation of c-jun NH2-terminal kinases. J. Biol. Chem. 271:15703-15707, 1996.
92. Maeda, K., Y. Yokokawa, M. Hatao, M. Naganuma, and Y. Tomita. Comparison of the melanogenesis in human black and light brown melanocytes. J. Dermatol. Sci. 14:199-206, 1997.
93. Marmol, V. D., F. Solano, A. Sels, G. Huez, A. Libert, F. Lejeune, and G. Ghanem. Glutathione depletion increases tyrosinase activity in human melanoma cells. J. Invest. Dermatol. 101:871-874, 1993.
94. Masamoto, Y., Y. Murata, Y. Baba, M. Tada, and K. Takahata. Inhibitory effects of esculetin on melanin biosynthesis. Biol. Pharm. Bull. 27:422-425, 2004.
95. Meier, B., H. H. Radeke, S. Selle, M. Younes, H. Sies, K. Resch, and G. G. Habermehl. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem. J. 263:539-545, 1989.
96. Menter, J. M., A. A. Etemadi, W. Chapman, T. D. Hollins, and I. Willis. In vivo depigmentation by hydroxybenzene derivatives. Melanoma Res. 6:443-449, 1993.
97. Mimouni, D., M. David, M. Feinmesser, C. I. Coire, and E. Hodak. Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides. Br. J. Dermatol. 145:1008-1014, 2001.
98. Minwalla, L., Y. Zhao, J. Cornelius, G. F. Babcock, R. R. Wickett, I. C. Le Poole, and R. E. Boissy. Inhibition of melanosome transfer from melanocytes to keratinocytes by lectins and neoglycoproteins in an in vitro model system. Pigment Cell Res.14: 185-194, 2001.
99. Miyamoto, L., and J. S. Taylor. Chemical leukoderma. In: Vitiligo: A Comprehensive Monograph on Basic and Clinical Science. S. K. Hann, and J. J. Nordlund (eds). Oxford: Blackwell Science, 2000, pp. 269-280.
100. Moon, K. Y., K. S. Ahn, J. Lee, and Y. S. Kim. Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells. Arch. Pharm. Res. 24:307-311, 2001.
101. Morelli, J. G., and D. A. Norris. Influence of inflammatory mediators and cytokines on human melanocytes function. J. Invest. Dermatol. 100:191S-195S, 1993.
102. Mun, Y. J., S. W. Lee, H. W. Jeong, K. G. Lee, J. H. Kim, and W. H. Woo. Inhibitory effect of miconazole on melanogenesis. Biol. Pharm. Bull. 27:806-809, 2004.
103. Naish-Byfield, S., and P. A. Riley. Tyrosinase kinetics: failure of acceleration in oxidation of ring-blocked monohydric phenol substrate. Pigment Cell Res. 11:94-97, 1998.
104. Nakajima, M., I. Shimoda, Y. Fukuwatari, and H. Hayasawa. Pigment Cell Res. 11:12-17, 1998.
105. Nakamura, K., M. Yoshida, H. Uchiwa, Y. Kawa, and M. Mizoguchi. Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism. Pigment Cell Res. 16:494-500, 2003.
106. Nappi, A. J., and E. Vass. Hydrogen peroxide generation associated with the oxidation of the eumelanin precursors 5,6-dihydroxyindole and 5,6-dihydroxy-2-carboxylic acid. Melanoma Res. 6:341-349, 1996.
107. Nazzaro-Porro, M. Azelaic acid. J. Am. Acad. Dermatol. 17:1033-1041, 1987.
108. Nazzaro-Porro, M., S. Passi, G. Zina, and A. S. Breathnach. Ten years' experience of treating lentigo maligna with topical azelaic acid. Acta Derm. Venereol. (Stockh). Suppl 143: 49-57, 1989.
109. Negroiu, G., N. Branza-Nichita, A. Petrescu, R. Dwek, and S. Petrescu. Protein specific N-glyscosylation of tyrosinase and tyrosinase-related protein-1 in B16 mouse melanoma cells. Biochem. J. 344:659-665, 1999.
110. Negroiu, G., R. A. Dwek, and S. M. Petrescu. Folding and maturation of tyrosinase-related protein-1 are regulated by the post-translational formation of disulfide bonds and by N-glycan processing. J. Biol. Chem. 275:32200-32207, 2000.
111. Negroiu, G., R. A. Dwek, and S. Petrescu. The inhibition of early N-glycan processing targets TRP-2 degradation in B16 melanoma cells. J. Biol. Chem. 278:27035-27042, 2003.
112. Nishiyama, T., J. Ohnishi, and Y. Hashiguchi. Fused heterocyclic antioxidants: antioxidative activities of hydrocoumarins in a homogeneous solution. Biosci. Biotechnol. Biochem. 65:1127-1133, 2001.
113. Njoo, M. D., W. Westerhof, J. D. Bos, and P. M. Bossuyt. The development of guidelines for the treatment of vitiligo. Arch. Dermatol. 135: 1514-1521, 1999.
114. O'Malley, M. A., T. Mathias, M. Priddy, D. Molina, A. A. Grote, and W. E. Halperin. Occupational vitiligo due to unsuspected presence of phenolic antioxidant byproducts in commercial bulk rubber. J. Occup. Med. 30:512-516, 1988.
115. Ochiai, Y., Y. Okano, Y. Funasaka, and M. Ichihashi. Effects of α-Toc on in vitro aged melanocytes. The 52nd Annual Meeting of the Central Division of Japanese Dermatological Association, 2001, p. 119.
116. Oettel, H. Die hydrochinovergiftung. Arch. Exp. Pathol. Pharmacol. 181:151-152, 1936.
117. Ohguchi, K., T. Tanaka, I. Iliya, T. Ito, M. Iinuma, K. Matsumoto, Y. Akao, and Y. Nozawa. Gnetol as a potent tyrosinase inhibitor from genus Gnetum. Biosci. Biotechnol. Biochem. 67:663-665, 2003.
118. Okamura, N., M. Asai, N. Hine, and A. Yagi. High-performance liquid chromatographic determination of phenolic compounds in Aloe species. J. Chromatogr. A. 746:225-231, 1996.
119. Oliver, E. A., L. Schwartz, and L. H. Warren. Occupational leukoderma. J. Am. Med. Assoc. 113:927-928, 1939.
120. Ortonne, J. P., D. B. Mosher, and T. B. Fitzpatrick. Topics in Dermatology: Vitiligo and Other Hypomelanoses of Hair and Skin. New York: Plenum, 1983.
121. Oyehaug, L., E. Plathe, D. I. Vage, and S. W. Omholt. The regulatory basis of melanogenic switching. J. Theor. Biol. 215:449-468, 2002.
122. Packer, L., H. Witt, and H. Tritscheler. Lipoic acid as a biological antioxidant. Free Rad. Biol. Med. 19:227-250, 1995.
123. Palumbo, A., M. d'Ischia, G. Misuraca, and G. Prota. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim. Biophys. Acta 1073:85-90, 1991.
124. Park, H. J., S. Gonzalez, M. A. Middelkamp-Hup, S. Kapasi, S. Peterson, and B. A. Gilchrest. Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation. J. Invest. Dermatol. 122.159-166, 2004.
125. Park, H. Y., and B. A. Gilchrest. More on MITF. J. Invest. Dermatol. 119:1218-1219, 2002.
126. Passi, S., and M. Nazzaro-Porro. Molecular basis of substrate and inhibitory specificity of tyrosinase: phenolic compounds. Br. J. Dermatol. 104:659-665, 1981.
127. Pawelek, J. M., and M. Murray. Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. Cancer Res. 46.493-497, 1986.
128. Perez-Bernal, A., M. A. Munoz-Perez, and F. Camacho. Management of facial hyperpigmentation. Am. J. Clin. Dermatol. 1:261-268, 2000.
129. Petrescu, S. M., A. J. Petrescu, H. N. Titu, R. A. Dwek, and F. M. Platt. Inhibition of N-Glycan processing in B16 melanoma cells results in activation of tyrosinase but does not prevent its transport to the melanosome. J. Biol. Chem. 272.15796-15803, 1997.
130. Piao, L. Z., H. R. Park, Y. K. Park, S. K. Lee, J. H. Park, and M. K. Park. Mushroom tyrosinase inhibition activity of some chromones. Chem. Pharm. Bull. 50.309-311, 2002.
131. Prota, G. Melanins and melanogenesis. New York: Academic Press, 1992, pp.1-290.
132. Qiu, L., M. Zhang, R. A. Sturm, B. Gardiner, I. Tonks, G. Kay, and P. G. Parsons. Inhibition of melanin synthesis by cystamine in human melanoma cells. J. Invest. Dermatol. 114.21-27, 2000.
133. Quevedo, W. C. Jr, T. J. Holstein, J. Dyckman, C. J. Mcdonald, and E. L. Isaacson. Inhibition of tanning response and immunosuppression by topical application of vitamin C and vitamin E to the skin of hairless (hr/hr) mice. Pigment Cell Res. 13.89-98, 2000.
134. Rafal, K. S., E. M. Griffiths, C. M. Ditre, L. J. Finkel, T. A. Hamilton, C. N. Ellis, and J. J. Voorhees. Topical tretinoin (retinoic acid) treatment for liver spot associated with photodamage. N. Engl. J. Med. 326:386-374, 1992.
135. Rees, J. L. Genetics of hair and skin color. Annu. Rev. Genet. 37:67-90, 2003.
136. Rhodes, L. E., G. Belgi, R. Parslew, L. McLoughlin, G. F. Clough, and P. S. Friedmann. Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. J. Invest. Dermatol. 117:880-885, 2001.
137. Riley, P. A., C. J. Cooksey, C. I. Johnson, E. J. Land, A. M. Latter, and C. A. Ramsden. Melanogenesis-targeted anti-melanoma prodrug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. Eur. J. Cancer 33.135-143, 1997.
138. Rodriguez-Vicente, J., V. Vicente-Ortega, M. Canteras-Jordana, and F. Calderon-Rubiales. Relationship between 4-hydroxyanisole toxicity and dopa oxidase activity for three melanoma cell lines. Melanoma Res. 7:373-381, 1997.
139. Romero, C., E. Aberdam, C. Larnier, and J. P. Ortonne. Retinoic acid as modulator of UVB-induced melanocyte differentiation. J. Cell. Sci. 107.1095-1103, 1994.
140. Ros, J. R., J. N. Rodriguez-Lopes, and F. Garcia-Canovas. Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. Biochem. J. 295.309-312, 1993.
141. Saliou, C., M. Kitazawa, L. McLaughlin, J. P. Yang, J. K. Lodge, T. Tetsuka, K. Iwasaki, J. Cillard, T. Okamoto, and L. Packer. Antioxidants modulate acute solar ultraviolet radiation-induced NF-Kappa-B activation in a human keratinocyte cell line. Free Rad. Biol. Med. 26.174-183, 1999.
142. Sanchez, J. L., and M. Vazquez. A hydroquinone solution in the treatment of melasma. Int. J. Dermatol. 21.55-58, 1982.
143. Sarkar, R., M. Bhalla, and A. J. Kanwar. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology 205:249-254, 2002.
144. Sasaki, K., and F. Yoshizaki. Nobiletin as a tyrosinase inhibitor from the peel of citrus fruit. Biol. Pharm. Bull. 25:806-808, 2002.
145. Sasaki, M., K. Kizawa, S. Igarashi, T. Horikoshi, H. Uchiwa, and Y. Miyachi. Suppression of melanogenesis by induction of endogenous intracellular metallothionein in human melanocytes. Exp. Dermatol. 13:465-471, 2004.
146. Schmitz, S., P. D. Thomas, T. M. Allen, M. J. Poznansky, and K. Jimbow. Dual role of melanins and melanin precursors as photoprotective and phototoxic agents: inhibition of ultraviolet radiation-induced lipid peroxidation. Photochem. Photobiol. 61.650-655, 1995.
147. Seiberg, M. Keratinocyte-melanocye interactions during melanosome transfer. Pigment Cell Res. 14:236-242, 2001.
148. Seiberg, M, C. Paine, E. Sharlow, M. Costanzo, P. Andrade-Gordon, M. Eisinger, and S. S. Shapiro. Inhibition of melanosome transfer results in skin lightening. J. Invest. Dermatol. 115.162-167, 2000.
149. Seiji, M., T. B. Fitzpatrick, and M. S. C. Birbeck. The melanosome: a distinctive subcellular particle of mammalian tyrosinase and the site of melanogenesis. J. Invest. Dermatol. 36:243-252, 1961.
150. Sharlow, E. R., C. Paine, L. Babiarz, M. Eisinger, S. S. Shapiro, and M. Seiberg. The protease activated receptor2 upregulates keratinocyte phagocytosis. J. Cell Sci. 113:3093-3101, 2000.
151. Shimizu, K., R. Kondo, K. Sakai, N. Takeda, T. Nagahata, and T. Oniki. Novel vitamin E derivative with 4-substituted resorcinol moiety has both antioxidant and tyrosinase inhibitory properties. Lipids 36: 1321-1326, 2001.
152. Shimogaki, H., Y. Tanaka, H. Tamai, and M. Masuda. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int. J. Cosmetic Sci. 22:291-303, 2000.
153. Sidi, E., J. Bourgeois-Spinasse, and P. Planat. Treatment of hyperpigmentations by hydroquinone derivatives. Presse Med. 69:2369-2372, 1961.
154. Slominski, A., D. J. Tobin, S. Shibahara, and J. Wortsman. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84.1155-1228, 2004.
155. Smith, C. J., K. B. O'Hare, and J. C. Alle. Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res. 1.386-389, 1988.
156. Smith, W. The effects of topical L (+) lactic acid and ascorbic acid on skin whitening. Int. J. Cosmetic Sci. 21:33-40, 1999.
157. Stoll, Jr. H. L. Squamous cell carcinoma. In: Dermatology in General Medicine, T. B. Fitzpatrick, A. Z. Eisen, K. Wolff, I. M. Freedberg, and K. F. Austen (eds). New York: McGraw-Hill, 1979, p. 362.
158. Straile, W. E. A study of the hair follicle and its melanocytes. Dev. Biol. 10:45-70, 1964.
159. Subbaramaiah, K., W. J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J. M. Pezzuto, and A. J. Dannenberg. Resvera-trol inhibits cycloxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273.21875-21882, 1998.
160. Sugimoto, K., T. Nishimura, K. Nomura, K. Sugimoto, and T. Kuriki. Chem. Pharm. Bull. 51.798-801, 2003.
161. Sugimoto, K., T. Nishimura, K. Nomura, K. Sugimoto, and T. Kuriki. Inhibitory effect of α-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol. Pharm. Bull. 27.510-514, 2004.
162. Suziki, I., S. Im, A. Tada, C. Scott, C. Akcali, M. B. Davis, G. Barsh, V. Hearing, and Z. Abdel-Malek. Participation of the melanocortin-1 receptor in the UV control of pigmentation. J. Invest. Dermatol. Symp. Proc. 4:329-344, 1999.
163. Szabo, G. The number of melanocytes in human epidermis. Br. Med. J. 1:1016-1017, 1954.
164. Szabo, G., A. B. Gerald, M. A. Pathak, and T. B. Fitzpatrick. Racial differences in the fate of melanosomes in human epidermis. Nature 222:1081-1082, 1969.
165. Tachibana, M. MITF: a stream flowing for pigment cells. Pigment Cell Res. 13:230-240, 2000.
166. Tada, A., I. Suzuki, S. Im, M. B. Davis, J. Cornelius, G. Babcock, J. J. Nordlund, and Z. Abdel-Malek. Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiations. Cell Growth Diff. 9:575-584, 1998.
167. Taki, T., and Y. Izawa. Surgical treatment of skin depigmentation caused by burn injuries. J. Dermatol. Surg. Oncol. 11:1218-1221, 1985.
168. Talwar, H. S., E. M. Griffiths, G. J. Fisher, A. Russman, K. Krach, S. Benrazavi, and J. J. Voorhees. Differential regulation of tyrosinase activity in skin of white and black individuals in vivo by topical retinoic acid. J. Invest. Dermatol. 100:800-805, 1993.
169. Thannickal, V. J., and B. L. Fanburg. Activation of an H2O2-generat-ing NADH oxidase in human lung fibroblasts by transforming growth factor-β1. J. Biol. Chem. 270:30334-30338, 1995.
170. Thomas, D. P., H. Kishi, H. Cao, M. Ota, T. Yamashita, S. Singh, and K. Jimbow. Selective incorporation and specific cytocidal effects as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs. J. Invest. Dermatol. 113:928-934, 1999.
171. Thorneby-Andersson, K., S. Olov, and C. Hansson. Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol. Pigment Cell Res. 13:33-38, 2000.
172. Tobin, D., A. G. Quinn, S. Ito, and A. J. Thody. The presence of tyrosinase and related proteins in human epidermis and their relationship to melanin type. Pigment Cell Res. 7:204-209, 1994.
173. Watabe, H., Y. Soma, M. Ito, Y. Kawa, and M. Mizoguchi. All-trans-retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor. J. Inv. Dermatol. 118:35-42, 2002.
174. Westerhof, W., and M. D. Njoo. In: A. D. Katsambas, and T. M. Lotti. European Handbook of Dermatological Treatments. Berlin: Springer, 1995, pp. 217-223.
175. Yamakoshi, J., F. Otsuka, A. Sano, S. Tokutake, M. Saito, M., Kikuchi, and Y. Kubota. Lightening effect on ultraviolet-induced pigmentation of guinea pig skin by oral administration of a proan-thocyanidin-rich extract from grape seeds. Pigment Cell Res. 16:629-638, 2003.
176. Yamamura, T., J. Onishi, and T. Nishiyama. Antimelanogenic activity of hydrocoumarins in cultured normal human melanocytes by stimulating intracellular glutathione synthesis. Arch. Dermatol. Res. 294:349-354, 2002.
177. Yang, F., and R. E. Boissy. Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes. Pigment Cell Res. 12:237-245, 1999.
178. Yasumoto, K., H. Watabe, J. C. Valencia, T. Kushimoto, T. Kobayashi, and V. J. Hearing. Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment. J. Biol. Chem. 279:28330-28338, 2004.
179. Yasumoto, K., K. Yokoyama, K. Takahashi, Y. Tamita, and S. Shibahara. Functional analysis of microphthalmia-associated transcription factor in pigment cell-specific transcription of the human tyrosinase family genes. J. Biol. Chem. 272:503-509, 1997.
180. Yokota, T., H. Nishio, Y. Kubota, and M. Mizoguchi. The inhibitory effect of glabridin from liquorice extracts on melanogenesis and inflammation. Pigment Cell Res. 11:355-361, 1998.
181. Yoshida, M., Y. Takahashi, and S. Inoue. Histamine induces melano-genesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J. Invest. Dermatol. 114:334, 2000.
182. Yoshimura, K., K. Tsukamoto, M. Okazaki, V. M. Virador, T. C. Lei, Y. Suzuki, G. Uchida, Y. Kitano, and K. Harii. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J. Dermatol. Sci. 27:68s-75s, 2001.
183. deopment and pigmentation in the mouse. Physiol. Zool. 24:1-8, 1951.
184. Danysz, J. De l'action du radium sur les différents tissus. C. R. Acad. Sci. Paris 136:461-464, 1903.
185. Hazen, H. Results of repeated epilation with roentgen rays in tinea tonsurans. Arch. Dermatol. 56:539-540, 1947.
186. Kawakami, T., R. Saito, and S. Miyazaki. Chronic radiodermatitis following repeated percutaneous transluminal coronary angioplasty. Br. J. Dermatol. 141:150-153, 1999.
187. Moshman, J., and A. Upton. Depigmentation of hair as a biological radiation dosimeter. Science 119:186-187, 1954.
188. Ortonne, J.-P., D. B. Mosher, and T. B. Fitzpatrick. Topics in Dermatology: Vitiligo and Other Hypomelanoses of Hair and Skin. New York: Plenum Publishing Corporation, 1983.
189. Pajonk, F., C. Weissenberger, and M. Henke. Vitiligo at sites of irradiation in a patient with Hodgkin's disease. Strahlenther. Onkol. 178:159-132, 2002.
190. Straile, W. E. A study of the hair follicle and its melanocytes. Dev. Biol. 10:45-70, 1964.
191. Taki, T., S. Kozuka, Y. Izawa, T. Usuda, M. Hiramatsu, T. Matsuda, K. Yokoo, Y. Fukaya, M. Tsubone, and J. Aoka. Surgical treatment of skin depigmentation caused by burn injuries. J. Dermatol. Surg. Oncol. 11:1218-1221, 1985.